Low-density lipoprotein receptor-related protein 1 promotes cancer cell migration and invasion by inducing the expression of matrix metalloproteinases 2 and 9.

The low-density lipoprotein receptor-related protein 1 (LRP1) is a multifunctional endocytic receptor involved in the metabolism of various extracellular ligands, including proteinases, that play critical roles in tumor invasion. Although several studies have shown an increased expression of LRP1 in cancer cells, its function in tumor development and progression remains largely unclear. Here, we reveal a novel mechanism by which LRP1 induces the expression of matrix metalloproteinase 2 (MMP2) and MMP9 and thereby promotes the migration and invasion of human glioblastoma U87 cells. Knockdown of LRP1 expression greatly decreased U87 cell migration and invasion, which was rescued by the forced expression of a functional LRP1 minireceptor. Inhibition of ligand binding to LRP1 by a specific antagonist, receptor-associated protein, also led to reduced cancer cell migration and invasion. Because MMPs play critical roles in cancer cell migration and invasion, we examined the expression of several MMPs and found that the expression of functional MMP2 and MMP9 was selectively decreased in LRP1 knockdown cells. More importantly, decreased cell migration and invasion of LRP1 knockdown cells were completely rescued by exogenous expression of MMP2 or MMP9, suggesting that these MMPs are likely downstream targets of LRP1-mediated signaling. We further show that the level of phosphorylated extracellular signal-regulated kinase (ERK) was significantly decreased in LRP1-silenced cells, suggesting that ERK is a potential mediator of LRP1-regulated MMP2 and MMP9 expression in U87 cells. Together, our data strongly suggest that LRP1 promotes glioblastoma cell migration and invasion by regulating the expression and function of MMP2 and MMP9 perhaps via an ERK-dependent signaling pathway.

[1]  D. Strickland,et al.  A novel mechanism for controlling the activity of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Multiple regulatory sites for 39-kDa receptor-associated protein. , 1992, The Journal of biological chemistry.

[2]  A. Schwartz,et al.  Receptor-mediated endocytosis of tissue-type plasminogen activator by low density lipoprotein receptor-related protein on human hepatoma HepG2 cells. , 1993, The Journal of biological chemistry.

[3]  M. Stearns,et al.  Decreased expression of the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor in invasive cell clones derived from human prostate and breast tumor cells. , 1994, Oncology research.

[4]  H. Geuze,et al.  39 kDa receptor‐associated protein is an ER resident protein and molecular chaperone for LDL receptor‐related protein. , 1995, The EMBO journal.

[5]  S. Grobmyer,et al.  Contrasting effects of plasminogen activators, urokinase receptor, and LDL receptor-related protein on smooth muscle cell migration and invasion. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[6]  G. Bu,et al.  Receptor-associated Protein Is a Folding Chaperone for Low Density Lipoprotein Receptor-related Protein* , 1996, The Journal of Biological Chemistry.

[7]  L. Matrisian,et al.  Changing views of the role of matrix metalloproteinases in metastasis. , 1997, Journal of the National Cancer Institute.

[8]  J. Verheijen,et al.  The Migration of Human Smooth Muscle Cells In Vitro Is Mediated by Plasminogen Activation and Can Be Inhibited by α2-Macroglobulin Receptor Associated Protein , 1997, Thrombosis and Haemostasis.

[9]  S. L. Gonias,et al.  Embryonic Fibroblasts That Are Genetically Deficient in Low Density Lipoprotein Receptor-related Protein Demonstrate Increased Activity of the Urokinase Receptor System and Accelerated Migration on Vitronectin* , 1997, The Journal of Biological Chemistry.

[10]  Yonghe Li,et al.  In vitro Invasiveness of Human Breast Cancer Cells Is Promoted by Low Density Lipoprotein Receptor-Related Protein , 1998, Invasion and Metastasis.

[11]  D. Boyd,et al.  Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion. , 1998, Cancer research.

[12]  J. Westermarck,et al.  Regulation of matrix metalloproteinase expression in tumor invasion , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  C. López-Otín,et al.  Collagenase-3 Binds to a Specific Receptor and Requires the Low Density Lipoprotein Receptor-related Protein for Internalization* , 1999, The Journal of Biological Chemistry.

[14]  R. Johnston,et al.  © 1999 Cancer Research Campaign Article no. bjoc.1998.0291 , 2022 .

[15]  C. López-Otín,et al.  Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase. , 2000, Journal of cell science.

[16]  D. Webb,et al.  Extracellular signal-regulated kinase functions in the urokinase receptor-dependent pathway by which neutralization of low density lipoprotein receptor-related protein promotes fibrosarcoma cell migration and matrigel invasion. , 2000, Journal of cell science.

[17]  G. Barlovatz-Meimon,et al.  Involvement of the [uPAR:uPA:PAI-1:LRP] complex in human myogenic cell motility. , 2000, Experimental cell research.

[18]  Differential expression of the alpha(2)-macroglobulin receptor and the receptor associated protein in normal human endometrium and endometrial carcinoma. , 2000, Molecular human reproduction.

[19]  Yonghe Li,et al.  The YXXL Motif, but Not the Two NPXY Motifs, Serves as the Dominant Endocytosis Signal for Low Density Lipoprotein Receptor-related Protein* , 2000, The Journal of Biological Chemistry.

[20]  P. Bornstein,et al.  Extracellular Matrix Metalloproteinase 2 Levels Are Regulated by the Low Density Lipoprotein-related Scavenger Receptor and Thrombospondin 2* , 2001, The Journal of Biological Chemistry.

[21]  P. Bornstein,et al.  The Low Density Lipoprotein Receptor-related Protein Modulates Levels of Matrix Metalloproteinase 9 (MMP-9) by Mediating Its Cellular Catabolism* , 2001, The Journal of Biological Chemistry.

[22]  D. Strickland,et al.  LRP: a multifunctional scavenger and signaling receptor. , 2001, The Journal of clinical investigation.

[23]  Rémy Ricoux,et al.  Promigratory effect of plasminogen activator inhibitor-1 on invasive breast cancer cell populations. , 2002, The American journal of pathology.

[24]  H. Bock,et al.  Lipoprotein receptors in the nervous system. , 2002, Annual review of biochemistry.

[25]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[26]  Yonghe Li,et al.  Essential role of the low density lipoprotein receptor‐related protein in vascular smooth muscle cell migration , 2003, FEBS letters.

[27]  László Patthy,et al.  Low Density Lipoprotein Receptor-related Protein Mediates Endocytic Clearance of Pro-MMP-2·TIMP-2 Complex through a Thrombospondin-independent Mechanism* , 2004, Journal of Biological Chemistry.

[28]  R. Béliveau,et al.  Expression of matrix metalloproteinases and their inhibitors in human brain tumors , 2004, Clinical & Experimental Metastasis.

[29]  V. Yong,et al.  The chemokine stromal cell derived factor-1 (CXCL12) promotes glioma invasiveness through MT2-matrix metalloproteinase. , 2005, Carcinogenesis.

[30]  R. Ala-aho,et al.  Matrix metalloproteinases as therapeutic targets in cancer. , 2005, Current cancer drug targets.

[31]  Wenyan Lu,et al.  Mesd binds to mature LDL-receptor-related protein-6 and antagonizes ligand binding , 2005, Journal of Cell Science.

[32]  K. Hess,et al.  Mechanisms of action of rapamycin in gliomas. , 2005, Neuro-oncology.

[33]  L. Martiny,et al.  Human thyroid carcinoma cell invasion is controlled by the low density lipoprotein receptor-related protein-mediated clearance of urokinase plasminogen activator. , 2006, The international journal of biochemistry & cell biology.

[34]  A. Teramoto,et al.  The expression of matrix metalloproteinase-2 and-9 in human gliomas of different pathological grades , 2006, Brain Tumor Pathology.

[35]  A. Gaultier,et al.  The Low-Density Lipoprotein Receptor-Related Protein Is a Pro-Survival Receptor in Schwann Cells: Possible Implications in Peripheral Nerve Injury , 2006, The Journal of Neuroscience.

[36]  T. Hori,et al.  Expression and quantitative analysis of matrix metalloproteinase-2 and-9 in human gliomas , 2006, Brain Tumor Pathology.

[37]  Sakae Tanaka,et al.  Tissue-type Plasminogen Activator Acts as a Cytokine That Triggers Intracellular Signal Transduction and Induces Matrix Metalloproteinase-9 Gene Expression* , 2006, Journal of Biological Chemistry.

[38]  Jayant P. Menon,et al.  Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. , 2006, Cancer cell.

[39]  B. Annabi,et al.  Decrease in LDL receptor‐related protein expression and function correlates with advanced stages of Wilms tumors , 2006, Pediatric blood & cancer.

[40]  C. Overall,et al.  Towards third generation matrix metalloproteinase inhibitors for cancer therapy , 2006, British Journal of Cancer.

[41]  L. Recht,et al.  Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  L. Muglia,et al.  Amyloid Precursor Protein Regulates Brain Apolipoprotein E and Cholesterol Metabolism through Lipoprotein Receptor LRP1 , 2007, Neuron.

[43]  B. Langlois,et al.  LRP-1 Silencing Prevents Malignant Cell Invasion despite Increased Pericellular Proteolytic Activities , 2008, Molecular and Cellular Biology.

[44]  Hong-Yu Zhang,et al.  Mutational analysis of the FXNPXY motif within LDL receptor-related protein 1 (LRP1) reveals the functional importance of the tyrosine residues in cell growth regulation and signal transduction. , 2008, The Biochemical journal.